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Abstract
Background: Post dural punction headache (PDPH) occurs in 10% to 40% of the patients who
had a lumbar puncture. Its symptoms can be severe and incapacitating. The epidural blood patch is
widely accepted as the treatment of choice for postdural puncture headache. Uncontrolled studies
report rapid recovery after patching in 90% to 100% of treated patients. However, sufficient
evidence from randomised, controlled clinical trials is lacking.
Methods: BLOPP (blood patch for post dural puncture headache) is a randomised, single centre,
observer-blind clinical trial. Patients with PDPH for at least 24 hours and at most 7 days after
lumbar puncture will be randomised to treatment with an epidural blood patch (EDBP) or to
conventional treatment, i.e. 24 hours bed rest and ample fluid intake. PDPH 24 hours after
treatment, classified on a 4-point scale (no, mild, moderate, severe) is the primary outcome. The
secondary outcome is the presence of PDPH 7 days after treatment. We estimated that a sample
size of 2 × 20 patients would provide us with a power of 80% to detect a relative reduction in
number of patients with persisting PDPH after 24 hours of 50% at the usual significance level α =
5%, taking into account that in approximately 10% of the patients the PDPH will have resolved
spontaneously after one day.
Discussion: The EDBP is accepted as the treatment of choice for PDPH although randomised,
controlled data is scarce. Our randomised, observer-blind clinical trial enables us to compare the
efficacy of two clinically practiced methods of PDPH treatment; EDBP versus conventional
treatment, as they are applied in clinical practise.
Background
Headache complicates approximately 10 to 40% of dural
punctures [1]. This postdural puncture headache (PDPH)
is typically orthostatic; provoked or aggravated by a verti-
cal or upright position and relieved by a horizontal posi-
tion. PDPH is probably caused by cerebral spinal fluid
leakage through the dural rent, into the epidural space.
The leakage causes a decrease in CSF pressure and volume,
leading to traction on pain-sensitive structures in an
upright position. Besides of headache, the patient may
complain of diplopia, tinnitus, dizziness, and myalgia.
PDPH may occur immediately after spinal tap, but it starts
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the patients. PDPH and accompanying symptoms are self-
limiting. They generally resolve within 7 days or less, in
80% of the cases. In a small minority of cases, the symp-
toms may persist for weeks or even months [2]. During an
episode of PDPH the patient may be completely incapac-
itated and confined to bed. Obviously this has financial,
social and psychological repercussions.
Different prophylactic measures such as: small needle
size, the use of Sprotte's needle, reinsertion of the stylet
before withdrawing the needle, and direction of the brevel
perpendicular to the dura, have all been shown to reduce
the occurrence of PDPH [3-6]. If, despite the prophylactic
measures, PDPH occurs, epidural blood patch (EDBP)
may be a beneficial therapeutic intervention. EDBP has
gained popularity as a therapeutic measure for PDPH. It
involves the injection of 10–20 ml of autologous blood
into the epidural space around the site of the spinal tap.
Gormly introduced this technique in the 1960's [1]. He
noticed that inadvertent bloody spinal taps were less often
complicated by PDPH. He theorised that the epidural
bleeding might lead to clot formation over the dural rent,
preventing CSF leakage into the epidural space. He there-
fore continued to treat 6 subjects suffering from PDPH
with EDBP, locating the epidural space with the hanging-
drop or loss of resistance method. All 6 subjects were
relieved of their complaints.
Many observational studies followed; they reported suc-
cess rates of the EDBP for PDPH between 70% and 90%
[7-12]. Seven controlled trials concerning prophylactic
treatment have been published [13-19]. One of these
studies was not blinded [18], three were not randomised
[14-16], one was only reported as an abstract [17]. One
other study [13] compared prophylactic EDBP versus no
blood patch among obstetric patients and reported a high
success rate. In this study adverse effects were not men-
tioned, which prevents firm conclusions. The latest study
[19], in which prophylactic EDBP was compared to a
sham procedure in a double blind setting, showed no
decrease in the incidence of PDPH between the two
groups. The effectiveness of prophylactic treatment does
not seem to have been established firmly.
Only one randomised and blinded trial concerning the
therapeutic effect of EDBP has been reported [20]. In this
study 12 patients, suffering from PDPH for more than 4
days, despite conservative treatment following lumbar
puncture, spinal anaesthesia or myelography, were ran-
domly allocated to EDBP or sham treatment. In the pla-
cebo group none of the patients noted complete relief of
pain. In the treatment group 5 of the 6 patients obtained
immediate relief. Subsequently placebo group patients
were also treated with an EDBP, resulting in complete
relief of PDPH in all patients. The size of the study, the
crossover effect, and the absence of any documentation
regarding the effectiveness of blinding of the observers
and patients, makes it difficult to draw firm conclusions
from this study.
A Cochrane review on prophylactic and therapeutic blood
patching [21] argued that further randomised trials of epi-
dural blood patching must be carried out before the bal-
ance of risks and benefits of this intervention can be
properly assessed".
Therefore, we decided to conduct a randomised, control-
led, clinical trial comparing the efficacy of the EDBP with
conservative treatment, consisting of 24 hours of bed rest
and adequate fluid intake for the treatment of PDPH.
Methods
Inclusion criteria
To be included in the study, patients should have PDPH
longer than 24 hours and not longer than 7 days after a
diagnostic spinal tap. Furthermore patients should be
aged 18 years or older. Written informed consent is
required.
Exclusion criteria
Excluded are patients with relative contra-indications for
lumbar puncture: hemorrhagic diathesis and space-occu-
pying intracranial lesions, and patients with a body tem-
perature over 38° Celsius.
Design
This is an observer-blind prospective, controlled and ran-
domised parallel group study.
Active treatment
Patients allocated to active treatment will receive an EDBP
on the day of randomisation. The subject is placed in the
lateral position, after which the back is flexed, sterilised
and draped. Sterile gloves are used. A needle (Spinocan
canule: 0.9 × 88 mm/206 × 3.5) is placed in the epidural
space, using the loss of resistance technique. Subse-
quently, 20 cc of blood is than drawn from the antecubital
vein, and injected slowly into the epidural space, after
which the needle is removed. The subject is held in the
supine position for a few minutes, after which there are no
further restrictions.
Control treatment
Conservative treatment consists of the advice to take 24
hours bed rest and drink at least 2.0 litres of fluid a day.
The use of painkillers is not prohibited. Treatment with
EDBP is not an option during the study period of 7 days,
not even when conservative treatment fails.Page 2 of 6
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The primary outcome is whether or not headache is
present at 24 hours after the start of treatment. Headache
is classified on a 4-point scale (no, mild, moderate,
severe). Mild headache is defined as: postural headache
slightly restricting daily activities. The patient is not con-
fined to bed and there are no associated symptoms. Mod-
erate headache: postural headache confining the patient to
bed for part of the day. Associated symptoms are not nec-
essarily present. Severe headache: postural headache where
the patient is bedridden for the entire day and associated
symptoms are always present. The associated symptoms
are: nausea, vomiting, dizziness, hearing loss, hyperacu-
sis, tinitus, photophobia, diplopia, stiffness of the neck
and scapular pain [2].
Secondary outcome measures are the presence of head-
ache at day seven after the start of treatment, and the
number of days until headache subsides.
Treatment complications
A systematic assessment of complications of EDBP will be
carried out. Back pain will be assessed systematically, and
classified as no, mild moderate, severe.
Statistical analysis
The number of patients with headache at 24 hours after
start of treatment will be compared between the two treat-
ment strategies. The effect of treatment on the occurrence
of the headache will be expressed as an odds ratio with
95% confidence interval. Adjustment for the effect of
potential confounders, such as age and sex, will be made
by multiple logistic regression analysis. The number of
days until headache relief will be compared with Kaplan-
Meier survival analysis techniques; observations will be
censored at the end of the study period, i.e. 7 days. Adjust-
ments for the effect of potential confounders will be made
with proportional hazards regression [22].
Sample size
A trial with 20 patients in each treatment group will pro-
vide us with a power (1-β) of 80% to detect a relative
reduction in number of patients with persisting PDPH
after 24 hours of 50% (OR = 12) and a power of 99% to
detect a relative risk reduction of 80%, (OR = 81, at the
usual significance level α = 5%, taking into account that in
approximately 10% of the patients the PDPH will have
resolved spontaneously after one day.
Recruitment of eligible patients
Patients receiving a diagnostic dural puncture are
informed about the possibility of developing PDPH. They
all receive written information about the study. A subject
suffering from headache after a dural puncture will be
advised to contact his physician. The physician evaluates
whether the headache is a PDPH or not. When the conclu-
sion is that the subject is suffering from PDPH, he or she
is asked to participate. Randomisation is done by a tele-
phone call, by the investigator.
Randomisation procedure
The randomisation procedure is carried out by one of the
investigators (RO or FvK). During the telephone contact,
while the patient is entered into the computer database
the treatment allocation (based on a random number gen-
erator) is provided by the computer. The patient cannot
be entered twice into the study, nor can the entry be
erased.
Ethical considerations and informed consent
The local medical ethics committee and review board
approved this study. Written informed consent will be
obtained from all patients, by asking them to return the
form by mail or in person, after the randomisation by
telephone.
Baseline data
At baseline, patient demographics age and gender will be
registered. Both have been proven to be independent risk
factors for the development of PDPH. Clinical characteris-
tics, such as headache characteristics, other complaints,
and use of analgesics will be noted. Information concern-
ing needle type, size and re-insertment of the stylet before
withdrawing is registered, since all three factors are inde-
pendent risk factors for the development of PDPH [3-5].
Furthermore the severity of the PDPH is registered on a
four-point scale.
Follow-up and blinding
The follow-up visits are carried out by telephone, by a
research nurse at the trial office, 24 hours after randomi-
sation, and at 1 week after randomisation. The research
nurse is kept blind to the treatment allocation. At the
beginning of the telephone interview the patients are
instructed not to inform the observer of the treatment
they received. The effectiveness of the blinding will be
checked in a sample of 12 patients, by letting the research
nurse fill in a forced choice item indicating the treatment
allocation.
Discussion
The EDBP, is widely accepted as the treatment of choice
for PDPH. In a review of the literature on this subject how-
ever, we found only little evidence to justify its use in gen-
eral practice [21]. Therefore, we decided to conduct an
observer blinded, randomised, controlled, study compar-
ing the therapeutic efficacy of the EDBP to the efficacy of
conservative treatment.Page 3 of 6
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tiveness of the EDBP, but also its efficiency. The number
of days spent with headache after treatment in the two
groups will be characterised as incapacitated-days. Imme-
diate relief of headache, and reduction of the number of
incapacitated-days is the ultimate goal of this treatment.
By taking into account the adverse effects of EBPD, most
notably lower back pain, we will be able to make a more
realistic estimate of the overall effect of EPBD.
The observer-blind method we have chosen enables us to
compare the two treatment strategies of interest as if they
are carried out in normal practise, without the artificial
circumstances created by sham treatment, in futile
attempts to maintain patient blinding. So a genuine com-
parison is made between the experimental treatment and
normal clinical practise. Because patients are of course
aware of the nature of the treatment, the study design lim-
its our ability to assess the placebo effect of the epidural
blood patch. One may argue that this may lead to overes-
timation of the effect of the blood patch. We think that for
a treatment of a self/limiting condition this is not really a
drawback. Another potential limitation is the small sam-
ple size of our study. Although our trial will turn out to be
the largest randomised study of therapeutic EDBP ever, a
sample size of 20 patients in each treatment group will
provide us sufficient power (1-β = 80%) to detect a rela-
tive reduction in the risk of PDPH after 24 hours of 50%.
Much depends therefore on our assumption that only in
approximately 10% of the patients the PDPH will have
resolved spontaneously after one day. Currently, the study
is well underway, and we expect to be able to report its
results in the end of 2005.
Schematic section through the vertebral column, showing the cauda equina and its covering membranes with the dural leakage site before (A) a d after (B) application of the epidural blood p tchFigure 1
Schematic section through the vertebral column, showing the cauda equina and its covering membranes with the dural leakage 
site before (A) and after (B) application of the epidural blood patch.Page 4 of 6
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EDBP is accepted as the treatment of choice for PDPH
although randomised, controlled data is scarce. Our ran-
domised, observer-blind clinical trial enables us to com-
pare the efficacy of two clinically practiced methods of
PDPH treatment; EDBP versus conventional treatment, as
they are applied in clinical practise.
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